AU2003214812A1 - Magnetic delivery compositions - Google Patents
Magnetic delivery compositionsInfo
- Publication number
- AU2003214812A1 AU2003214812A1 AU2003214812A AU2003214812A AU2003214812A1 AU 2003214812 A1 AU2003214812 A1 AU 2003214812A1 AU 2003214812 A AU2003214812 A AU 2003214812A AU 2003214812 A AU2003214812 A AU 2003214812A AU 2003214812 A1 AU2003214812 A1 AU 2003214812A1
- Authority
- AU
- Australia
- Prior art keywords
- delivery compositions
- magnetic delivery
- magnetic
- compositions
- delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Ceramic Engineering (AREA)
- Nanotechnology (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34778602P | 2002-01-09 | 2002-01-09 | |
| US60/347,786 | 2002-01-09 | ||
| PCT/US2003/000489 WO2003059325A1 (fr) | 2002-01-09 | 2003-01-07 | Compositions a administration par voie magnetique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003214812A1 true AU2003214812A1 (en) | 2003-07-30 |
Family
ID=23365270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003214812A Abandoned AU2003214812A1 (en) | 2002-01-09 | 2003-01-07 | Magnetic delivery compositions |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003214812A1 (fr) |
| WO (1) | WO2003059325A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105903030B (zh) * | 2016-04-22 | 2019-01-15 | 山西大学 | 一种酯化胆酸/Fe3O4磁性纳米复合体及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4345588A (en) * | 1979-04-23 | 1982-08-24 | Northwestern University | Method of delivering a therapeutic agent to a target capillary bed |
| US5122418A (en) * | 1985-12-09 | 1992-06-16 | Shiseido Company Ltd. | Composite powder and production process |
| US5549915A (en) * | 1993-01-29 | 1996-08-27 | Magnetic Delivered Therapeutics, Inc. | Magnetically responsive composition for carrying biologically active substances and methods of production |
| US5411730A (en) * | 1993-07-20 | 1995-05-02 | Research Corporation Technologies, Inc. | Magnetic microparticles |
-
2003
- 2003-01-07 WO PCT/US2003/000489 patent/WO2003059325A1/fr not_active Ceased
- 2003-01-07 AU AU2003214812A patent/AU2003214812A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003059325A1 (fr) | 2003-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AUPS146402A0 (en) | Nanofiller compositions | |
| AU2003251323A1 (en) | Delivery devices | |
| AU2003254863A1 (en) | Herbicide compositions | |
| AU2003228766A1 (en) | Polyester compositions | |
| AU2003279340A1 (en) | Shampoo compositions | |
| AU2003303772A1 (en) | Polyester compositions | |
| AU2003285288A1 (en) | Composition | |
| AU2003254544A1 (en) | Compositions comprising lactoferrin | |
| AU2003301654A1 (en) | Stabilized composition | |
| AU2002950744A0 (en) | Composition | |
| AU2003291869A1 (en) | Fuel compositions | |
| AU2003234909A1 (en) | Powder composition | |
| AU2003235708A1 (en) | Polytartrate composition | |
| AU2003242760A1 (en) | Coating compositions | |
| AU2003302305A1 (en) | Benzoquinolizine-2-carboxylic acid-containing compositions | |
| AU2003208411A1 (en) | Anti-glycolytic composition | |
| AU2003269904A1 (en) | Antigen-polymer compositions | |
| AU2003282722A1 (en) | Therapeutic compositions | |
| AU2003293621A1 (en) | Liposome-forming compositions | |
| AU2003269177A1 (en) | Antimicrobial compositions | |
| AU2003901311A0 (en) | Coating compositions | |
| AUPS153202A0 (en) | Novel anti-bacterial compositions | |
| AU2003216503A1 (en) | Stable pharmaceutical compositions | |
| AU2003208841A1 (en) | Gasolinen compositions | |
| AU2003100144A4 (en) | Lousicide composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |